Research Article
Low-Dose Steroid Therapy Is Associated with Decreased IL-12 Production in PBMCs of Severe Septic Patients
Table 1
Clinical characteristics of severe septic patients with and without low-dose steroid use (percentage, mean ± standard error mean).
| | No-low-dose steroid () | Low-dose steroid () | value |
| Age (years old) | 72.3 ± 6.4 | 72.1 ± 2.2 | 0.132 | Male | 64 | 72 | 0.694 | APACHE II score | 24.5 ± 2.4 | 29.2 ± 1.5 | 0.142 | History | | | | COPD | 36 | 22 | 0.433 | Heart failure | 9 | 11 | 1.000 | Hypertension | 45 | 22 | 0.237 | Diabetes mellitus | 0 | 22 | 0.268 | End stage renal disease | 0 | 6 | 1.000 | Liver cirrhosis | 9 | 11 | 1.000 | Infection source | | | 0.595 | Pneumonia | 91 | 78 | | Urinary tract infection | 9 | 16 | | Biliary tract infection | 0 | 6 | | Initial antibiotics for pathogens | | | 0.367 | Sensitive | 36 | 61 | | Resistant | 36 | 28 | | No pathogen isolated | 27 | 11 | |
|
|
APACHE = acute physiology and chronic health evaluation; COPD = chronic obstructive pulmonary disease.
|